Approval processes for new drugs and medical technologies under review in Brisbane

On Monday 17 and Tuesday 18 May 2021 the House of Representatives Standing Committee on Health, Aged Care and Sport will hold two days of public hearings in Brisbane as part of the Committee’s ongoing inquiry into approval processes for new drugs and novel medical technologies in Australia.

The Committee will hear evidence from numerous stakeholders including patient advocacy groups, industry, researchers and clinicians. The program for the hearings is available on the Committee’s website.

The Chair of the Committee, Mr Trent Zimmerman MP, commented that ‘the inquiry has received significant interest from the community, and these hearings will enable the Committee to hear from Queensland stakeholders about how to further strengthen Australia’s development and approval processes for new medicines and novel medical technologies.’

‘A particular focus of these hearings will be patient involvement in the development and approval processes for new therapies’ Mr Zimmerman added. ‘The Committee will also continue to explore the important issues that have emerged during the inquiry, including how to better attract clinical trials to Australia, how the approvals process for new drugs and technologies can be made more efficient, and how Australia can encourage the development and approval of treatments for rare diseases.’

Further information about the Committee’s inquiry including the full terms of reference are available at the Committee’s website. Interested parties can listen to the audio live streaming click here.

Interested members of the public may wish to track the inquiry via the website. Click on the blue ‘Track Committee’ button under the inquiry name and use the forms to login to My Parliament or to register for a My Parliament account.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.